Cargando…
Conversion to belatacept after lung transplantation: Report of 10 cases
BACKGROUND: Calcineurin inhibitors (CNIs) remain the cornerstone of maintenance immunosuppression (IS) after lung transplantation (LTx), although CNI-related life-threatening toxic effects may occur. Belatacept, a novel immunosuppressant that blocks a T-cell co-stimulation pathway, is a non-nephroto...
Autores principales: | Brugière, Olivier, Vallée, Alexandre, Raimbourg, Quentin, Peraldi, Marie-Noelle, de Verdière, Sylvie Colin, Beaumont, Laurence, Hamid, Abdulmonem, Zrounba, Mathilde, Roux, Antoine, Picard, Clément, Parquin, François, Glorion, Matthieu, Oniszczuk, Julie, Hertig, Alexandre, Mal, Hervé, Bunel, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016650/ https://www.ncbi.nlm.nih.gov/pubmed/36920935 http://dx.doi.org/10.1371/journal.pone.0281492 |
Ejemplares similares
-
Results of Lung Transplantation for Cystic Fibrosis With Selected Donors Over 65 Years Old
por: Glorion, Matthieu, et al.
Publicado: (2023) -
Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection
por: Farfour, Eric, et al.
Publicado: (2023) -
Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability
por: Mantov, Nikola, et al.
Publicado: (2022) -
Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient
por: Glorion, M., et al.
Publicado: (2021) -
Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)